Pharmacologic management of spasticity in cerebral palsy.
Mooney
James F
JF
Department of Orthopaedic Surgery, Children's Hospital of Michigan, Detroit, Michigan 48201, USA. jfm3md@aol.com
Koman
L Andrew
LA
Smith
Beth P
BP
D001418:Baclofen / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D003975:Diazepam / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007278:Injections, Spinal; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use*; D019800:Phenol / Q000627:therapeutic use
D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D019800:Phenol; D000431:Ethanol; D001905:Botulinum Toxins; D001418:Baclofen; D003975:Diazepam